Hepatitis C Hepatitis C  Infection in these people is associated with an unusually rapid progression to cirrhosis.  People with stable HIV who never received medication for HCV, may be treated with a combination of peginterferon plus ribavirin with caution to the possible side effects. As of 2011, there are about one hundred medications in development for hepatitis C.  These include vaccines to treat hepatitis, immunomodulators, and cyclophilin inhibitors, among others.  These potential new treatments have come about due to a better understanding of the hepatitis C virus.  There are a number of vaccines under development and some have shown encouraging results. The combination of sofosbuvir and velpatasvir in one trial  resulted in cure rates of 99% Hepatitis C Hepatitis C